CD40-CD154 interaction and IFN-γ are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1384-1391

  Aloisi, Francesca ^a   Penna, Giuseppe ^b   Polazzi, Elisabetta ^a   Minghetti, Luisa ^a   Adorini, Luciano ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; ASTROCYTE; BRAIN; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD40; ASTROCYTES; CD40 LIGAND; CELL ADHESION; CELL COMMUNICATION; CELLS, CULTURED; DINOPROSTONE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERLEUKIN-12; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MICROGLIA; OVALBUMIN; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; TH1 CELLS; TH2 CELLS;

EID: 0033083789     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. 1998. The interleukin-12/interleukin-12 receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495.
2. Bi, Z., P. Quandt, T. Komatsu, M. Barna, and C. S. Reiss. 1995. IL-12 promotes enhanced recovery from vescicular stomatitis virus infection of the central nervous system. J. Immunol. 155:5684.
3. Sato, S., S. L. Reiner, M. A. Jensen, and R. P. Roos. 1997. Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection. J. Neuroimmunol. 76:213.
4. Trembleau, S., T. Germann, M. K. Gately, and L. Adorini. 1995. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 16:383.
5. Issazadeh, S., Å. Ljungdahl, B. Höjeberg, M. Mustafa, and T. Olsson. 1995. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, tumor necrosis factor a and tumor necrosis factor β. J. Neuroimmunol. 61:205.
6. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. N. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86). and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985.
7. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381.
8. Santambrogio, L., G. M. Crisi, J. Leu, G. M. Hochwald, T. Ryan, and G. J. Thorbecke. 1995. Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis. J. Neuroimmunol. 58:211.
9. Kreutzberg, G. W. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:312.
10. De Simone, R., A. Giampaolo, B. Giometto, P. Gallo, G. Levi, C. Peschle, and F. Aloisi. 1995. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol. 54:175.
11. Bö, L., J. W. Peterson, P. A. Hoffman, W. M. Gallatin, R. M. Ransohoff, and B. D. Trapp. 1996. Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the β-2 integrin LFA-1 in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55:1060.
12. Gerritse, K., J. D. Laman, R. J. Noelle, A. Aruffo, J. A. Ledbetter, W. J. A. Boersma, and E. Claassen. 1996. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA. 93:2499.
13. + T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27:2840.
14. Stalder, A. K., A. Pagenstecher, N. C. Yu, C. Kincaid, C.-S. Chiang, M. V. Hobbs, F. E. Bloom, and I. L. Campbell. 1997. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J. Immunol. 159:1344.
15. Park, J.-H., and S.-H. Shin. 1996. Induction of IL-12 gene expression in the brain in septic shock. Biochem. Biophys. Res. Commun. 224:391.
16. Becher, B., V. Dodelet, V. Fedorowicz, and J. P. Antel. 1996. Soluble tumor necrosis factor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invest. 98:1539.
17. Aloisi, F., G. Penna, J. Cerase, B. Menèndez Iglesias, and L. Adorini. 1997. IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159:1604.
18. Frei, K., C. Siepl, P. Groscurth, S. Bodmer, C. Schwerdel, and A. Fontana. 1987. Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur. J. Immunol. 17:1271.
19. Matsumoto, Y., Ohmori, K., and M. Fujiwara. 1992. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology 76:209.
20. + T lymphocytes in the central nervous system. Clin. Exp. Immunol. 98:313.
21. Ford, A. L., E. Foulcher, F. A. Lemckert, and J. D. Sedgwick. 1996. Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 184:1737.
22. Aloisi, F., F. Ria, G. Penna, and L. Adorini. 1998. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J. Immunol. 160:4671.
23. Costantinescu, C. S., K. Frei, M. Wysocka, G. Trinchieri, U. Malipiero, A. Rostami, and A. Fontana. 1996. Astrocytes and microglia produce interleukin-12 p40. Ann. NY Acad. Sci. 795:328.
24. Minghetti, L., and G. Levi. 1995. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J. Neurochem. 65:2690.
25. Murphy, S., B. Pearce, J. Jeremy, and P. Dandona. 1988. Astrocytes as eicosanoid-producing cells. Glia 1:241.
26. Minghetti, L., and Levi G. 1998. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Progr. Neurobiol. 54:99.
27. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:108.
28. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150:5321.
29. 2 at priming of naive CD4 T cells inhibits acquisition of ability to produce IFN-γ and IL-2, but not IL-4 and IL-5. J. Immunol 155:4604.
30. 2 primes naive T cells for the production of antiinflammatory cytokines. Eur. J. Immunol. 27:3526.
31. van der Pouw Kran, T. C. T. M., L. C. M. Boeije, R. J. T. Smeenk, J. Wijdenes, and L. A. Aarden. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:775.
32. 2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161:2723.
33. Khoury, S. J., W. W. Hancock, and H. L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E in the brain. J. Exp. Med. 176:1355.
34. Reder, A. T., M. Thapar, A. M. Sapugay, and M. Jensen. 1994. Prostaglandins and inhibitors of arachidonate metabolism suppress experimental allergic encephalomyelitis. J. Neuroimmunol 54:117.
35. lo thymocytes in vivo. Science 250:1720.
36. + T cell population to the T helper 2 pathway. J. Immunol. 157:3260.
37. Adorini, L., E. Appella, G. Doria, and Z. A. Nagy. 1988. Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 168:2091.
38. 2-microglobulin-deficient BALB/c mice. J. Exp. Med. 183:485.
39. Shu, U., M. Kiniwa, C. Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125.
40. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane. A Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
41. 2 by transforming growth factor β and interleukin 10 in activated microglial cultures. J. Neuroimmunol. 82:31.
42. Ria, F., G. Penna, and L. Adorini. 1998. Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells. Eur. J. Immunol. 28:2003.
43. Kennedy, M. K., K. S. Picha, W. C. Fanslow, K. H. Grabstein, M. R. Alderson, K. N. Clifford, W. A. Chin, and K. M. Mohler. 1996. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26:370.
44. Ando, D. G., J. Clayton, D. Kono, J. L. Urban, and E. E. Sercarz. 1989. Encephalitogenic T cells in the B10. PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol. 124:132.
45. Kennedy, M. K., D. S. Torrance, K. S. Picha, and K. M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496.
46. + T cells in autoimmune infiltrates in experimental allergic encephalomyelitis. Int. Immunol. 6:347.
47. Cannella, B., and C. S. Raine. 1995. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:424.
48. Navikas, V., and H. Link. 1996. Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:322.
49. Rot, O., B. Fleischer, and E. Cash. 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1434.
50. Xiao, B. G., X. F. Bai, G. X. Zhang, and H. Link. 1998. Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats. J. Neuroimmunol. 84:230.
51. Cannella, B., Y. L. Gao, C. Brosnan, and C. S. Raine. 1996. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:735.
52. Tanuma, N., T. Kojima, T. Shin, Y. Aikawa, T. Kohji, Y. Ishihara, and Y. Matsumoto. 1997. Competitive PCR quantification of pro- and antiinflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis. J. Neuroimmunol. 73:197.
53. Mathisen, P. M., M. Yu. J. M. Johnson, J. A. Drazba, and V. K. Tuohy. 1997. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 186:159.
54. Griffin, D. E., S. L. Wesselingh, and J. C. McArthur. 1994. Elevated central nervous system proslaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35:592.
55. Fretland, D. J. 1992. Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis. Prostaglandins Leukot. Essent. Fatty Acids 45:249.
56. O'Banion, M. K., J. C. Miller, J. W. Chang, M. D. Kaplan, and P. D. Coleman. 1996. Interleukin-1β induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J. Neurochem. 66:2532.
57. 2 production. Glia 21:183.
58. + T-cell responses. Immunol. Today 17:410.